Cedars Sinai Medical Center
Government organization
Active
Los Angeles, United States
20
28M
16
0.17
1
0.20
3
- Areas of investment
Summary
Cedars Sinai Medical Center appeared to be the Corporate Investor, which was created in 1902. The company was established in North America in United States. The main department of described Corporate Investor is located in the Los Angeles.
The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Cedars Sinai Medical Center works on 0 percentage points less the average amount of lead investments. The important activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015.
The fund was created by Kaspare Cohn.
Among the most popular portfolio startups of the fund, we may highlight Capricor Therapeutics, Emulate, Health Care DataWorks. Among the most successful fund investment fields, there are Biotechnology, Wellness. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cedars Sinai Medical Center, startups are often financed by The Cedars-Sinai Accelerator, Techstars, Techammer. The meaningful sponsors for the fund in investment in the same round are NanoDimension, Vertical Venture Partners, Techstars. In the next rounds fund is usually obtained by Techammer, OS Fund, National Institutes of Health.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 1
- Exits
- 3
- Rounds per year
- 0.17
- Follow on index
- 0.20
- Investments by industry
- Health Care (17)
- Medical (12)
- Biotechnology (6)
- Health Diagnostics (5)
- Information Technology (3) Show 17 more
- Investments by region
-
- United States (19)
- United Kingdom (1)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 186M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.05
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Azra Care | 21 Feb 2023 | Health Care, Medical | Seed | 120K | United States, California, San Francisco |
| Wellist | 08 May 2018 | Health Care, Medical | Early Stage Venture | 10M | United States, Boston, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.